SHANGHAI, June 12,
2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD)
("Zhongchao" or the "Company"), a platform-based internet
technology company offering services for patients with cancer and
other major diseases, today announced the launch of the Digital
Online Education Platform for Common Diseases Clinical Diagnosis
and Treatment (the "Platform"). This Platform is designed to
elevate the clinical decision-making acumen and patient service
capabilities of healthcare professionals, thereby delivering
optimal solutions for clinical diagnoses and treatments of
prevalent diseases.
The scope of common diseases includes cardiovascular and
cerebrovascular diseases, cancer, chronic respiratory diseases,
diabetes, and other major chronic diseases. These medical
conditions pose both significant and enduring health risks to
patients due to their high incidence rate. In 2021, the premature
death rate in China from four
types of major chronic diseases, namely cardiovascular and
cerebrovascular diseases, cancer, chronic respiratory diseases, and
diabetes, was 15.3%. Timely, scientific, and efficacious treatment
strategies are paramount in assuaging the suffering of patients
from common diseases and enhancing the prognosis of these diseases.
As of the end of 2021, China had
approximately 4.28 million physicians. Given the sheer volume of
patients afflicted with common diseases, the medical fraternity
grapples with colossal pressure, signaling an urgent need to
amplify diagnostic efficiency and bolster patient service
capabilities.
In alignment with the Guidance on Strengthening Continuing
Medical Education by China's
National Health Commission, major administrative regions including
provinces, cities, counties, and districts in China are poised to fully adopt information
management for continuing medical education and conduct suitable
continuing medical education activities by leveraging the power of
distance education methods. In light of this development,
Zhongchao established the Platform to follow clinical practice
guidelines, standardize diagnostic and treatment behaviors, and
facilitate diagnostic and treatment experiences sharing. This
Platform enables physicians to access educational content
conveniently through various digital devices, including computers,
tablets, and mobile phones.
The Company is committed to building the Platform a reservoir of
systematic courses curated by experts from various fields across
the country. The content covers 19 disciplines, including
cardiology, respiratory medicine, gastroenterology, infectious
disease, rheumatology and immunology, nephrology, hematology,
endocrinology, neurology, psychiatry, vascular surgery,
orthopedics, urology, neurosurgery, obstetrics and gynecology,
otolaryngology, hepatology, pediatrics, and parenteral nutrition,
12 of which involve major diseases such as cancer.
Mr. Weiguang Yang, Chairman and
Chief Executive Officer of Zhongchao, commented, "We are excited
about the launch of the Platform. We expect that the Platform will
be instrumental in providing high-caliber education and training
services for Chinese physicians across a more diverse range of
disciplines and on a wider scale. This initiative serves our
broader mission of promoting physicians to improve their
diagnostic and treatment capabilities and ultimately culminate in
greater benefits for patients."
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in
the Cayman Islands. It
consolidates the financial results of a variable interest entity,
Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries (the
"PRC operating entities") through a series of contractual
arrangements. Zhongchao Inc. is a platform-based internet
technology company offering services to patients with oncology and
other major diseases. The PRC operating entities provide online
healthcare information, professional training and educational
services to healthcare professionals under their "MDMOOC" platform
(www.mdmooc.org), offer patient management services in the
professional field of tumor and rare diseases through Zhongxin,
offer internet healthcare services through Zhixun Internet
Hospital, and pharmaceutical services through Xinjiang Medical and
operate an online information platform, Sunshine Health Forums, to
general public. More information about the Company can be found at
its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's future
business development; product and service demand and acceptance;
changes in technology; economic conditions; the growth of the
professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 13901629242
Investor Relations: Sherry
Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:https://www.prnewswire.com/news-releases/zhongchao-inc-launch-digital-online-education-platform-for-common-diseases-clinical-diagnosis-and-treatment-301847878.html
SOURCE Zhongchao Inc.